The Allstate Co. (NYSE:ALL) Stake Reduced by Associated Banc Corp

Associated Banc Corp reduced its stake in shares of The Allstate Co. (NYSE:ALL) by 3.3% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 115,716 shares of the insurance provider’s stock after selling 3,900 shares during the quarter. Associated Banc Corp’s holdings in Allstate were worth $21,946,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in ALL. Northwest Investment Counselors LLC bought a new position in Allstate during the 3rd quarter worth $28,000. Catalyst Capital Advisors LLC bought a new position in shares of Allstate in the third quarter worth $29,000. Versant Capital Management Inc grew its stake in shares of Allstate by 70.9% in the second quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock worth $30,000 after purchasing an additional 78 shares in the last quarter. Family Firm Inc. bought a new position in shares of Allstate in the second quarter worth $38,000. Finally, MCF Advisors LLC grew its stake in shares of Allstate by 33.9% in the second quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock worth $53,000 after purchasing an additional 84 shares in the last quarter. 76.47% of the stock is currently owned by institutional investors.

Allstate Stock Up 0.1 %

ALL stock traded up $0.27 during mid-day trading on Monday, hitting $204.07. The stock had a trading volume of 42,628 shares, compared to its average volume of 1,537,111. The company has a current ratio of 0.40, a quick ratio of 0.40 and a debt-to-equity ratio of 0.43. The Allstate Co. has a 1-year low of $134.17 and a 1-year high of $205.35. The company has a fifty day moving average of $191.41 and a 200 day moving average of $177.90. The stock has a market capitalization of $54.04 billion, a price-to-earnings ratio of 13.20, a PEG ratio of 1.81 and a beta of 0.48.

Allstate (NYSE:ALL) last issued its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, beating analysts’ consensus estimates of $2.20 by $1.71. The business had revenue of $16.63 billion for the quarter, compared to analyst estimates of $14.57 billion. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The firm’s revenue for the quarter was up 14.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.81 EPS. On average, equities analysts expect that The Allstate Co. will post 16.07 EPS for the current fiscal year.

Allstate Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, January 2nd. Stockholders of record on Friday, November 29th will be issued a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a dividend yield of 1.80%. The ex-dividend date is Friday, November 29th. Allstate’s dividend payout ratio is 23.83%.

Insider Activity

In other Allstate news, insider John E. Dugenske sold 36,367 shares of the firm’s stock in a transaction that occurred on Friday, September 20th. The stock was sold at an average price of $191.38, for a total value of $6,959,916.46. Following the sale, the insider now owns 27,364 shares of the company’s stock, valued at $5,236,922.32. This trade represents a 57.06 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 1.80% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the company. BMO Capital Markets increased their price target on Allstate from $205.00 to $214.00 and gave the stock an “outperform” rating in a research note on Friday, October 18th. JPMorgan Chase & Co. upped their price objective on Allstate from $205.00 to $207.00 and gave the company an “overweight” rating in a report on Thursday, October 10th. TD Cowen upped their price objective on Allstate from $193.00 to $224.00 and gave the company a “buy” rating in a report on Tuesday, September 3rd. Bank of America upped their price objective on Allstate from $216.00 to $233.00 and gave the company a “buy” rating in a report on Friday, October 18th. Finally, Evercore ISI upped their price objective on Allstate from $191.00 to $195.00 and gave the company an “in-line” rating in a report on Wednesday, October 9th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $214.19.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.